{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:50Z","timestamp":1792784870254,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X021351\/1"],"award-info":[{"award-number":["MR\/X021351\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X021351\/1"],"award-info":[{"award-number":["MR\/X021351\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Exeter Biomedical Research Centre - Mid-Career fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberous sclerosis complex (TSC) is a genetic multisystem disorder regarded as having near-complete penetrance, a view largely derived from clinically ascertained cohorts. As genomic newborn screening is piloted internationally, robust estimates of penetrance and expressivity in unselected populations are urgently needed. We analysed genome sequencing data from &gt;900,000 adults in UK Biobank (UKB) and the All of Us Research Program (AoU), representing multiple genetic ancestries, to identify individuals carrying high-confidence ACMG\/AMP (likely) pathogenic\n                    <jats:italic>TSC1<\/jats:italic>\n                    \/\n                    <jats:italic>TSC2<\/jats:italic>\n                    variants. Electronic health records and self-reported data were interrogated for TSC-related phenotypes, including diagnostic codes, and evidence of\u00a0epilepsy, chronic kidney disease and other hamartomas. We identified 61 adults with (likely) pathogenic\n                    <jats:italic>TSC1<\/jats:italic>\n                    \/\n                    <jats:italic>TSC2<\/jats:italic>\n                    variants and phenotype data available. Only 20\/61 (33%) had a recorded diagnosis of TSC and a further 8\/61 (13%) had at least one TSC phenotype; 33\/61 (54%) had no recorded TSC diagnosis, manifestations or suggestive medication history, despite median age \u226555 years (UKB\u2009\u2265\u200975 years) with extensive longitudinal healthcare data. Apparent reduced penetrance was observed for\n                    <jats:italic>TSC1<\/jats:italic>\n                    in both cohorts (46.6% UKB, 46.1% AoU), consistent with previously reported milder phenotypes associated with this gene. Apparent\n                    <jats:italic>TSC2<\/jats:italic>\n                    penetrance was also incomplete (27.8% UKB, 66.7% AoU,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.038, not significant after Bonferroni correction). Borderline significant apparent penetrance differences between UKB and AoU were not explained by gene, variant class, or ClinVar designation, but may reflect healthy volunteer bias in UKB. Overall, these findings challenge the assumption of near-complete penetrance for (likely) pathogenic\n                    <jats:italic>TSC1<\/jats:italic>\n                    \/\n                    <jats:italic>TSC2<\/jats:italic>\n                    variants and have important implications for genomic newborn screening, variant interpretation and counselling of asymptomatic carriers.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02107-9","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:14:28Z","timestamp":1779113668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncovering apparent incomplete penetrance of TSC1\/TSC2 variants: Insights from multiple population cohorts and implications for newborn screening"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7614-9202","authenticated-orcid":false,"given":"J.","family":"Fasham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McPhater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Whittington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7334-0602","authenticated-orcid":false,"given":"A. T.","family":"Pagnamenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8548-447X","authenticated-orcid":false,"given":"T. S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. R.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Weedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-3411","authenticated-orcid":false,"given":"E. L.","family":"Baple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-5076","authenticated-orcid":false,"given":"C. F.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-5295","authenticated-orcid":false,"given":"L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2107_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/tacg.S90262","volume":"10","author":"C Caban","year":"2017","unstructured":"Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet. 2017;10:1\u20138. https:\/\/doi.org\/10.2147\/tacg.S90262.","journal-title":"Appl Clin Genet"},{"key":"2107_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb37754.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2107_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1017\/cjn.2023.332","volume":"51","author":"D Pal","year":"2024","unstructured":"Pal D, Forster N, Madan M, Whitney R, Farncombe KM, Kim RH. Retrospective Analysis of Canadian Adults with Tuberous Sclerosis Complex. Can J Neurol Sci. 2024;51:636\u201343. https:\/\/doi.org\/10.1017\/cjn.2023.332.","journal-title":"Can J Neurol Sci"},{"key":"2107_CR4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1086\/302322","volume":"64","author":"VM Rose","year":"1999","unstructured":"Rose VM, Au KS, Pollom G, Roach ES, Prashner HR Northrup H. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet. 1999;64:986\u201392. https:\/\/doi.org\/10.1086\/302322.","journal-title":"Am J Hum Genet"},{"key":"2107_CR5","doi-asserted-by":"publisher","first-page":"101443","DOI":"10.1016\/j.gim.2025.101443.","volume":"27","author":"T Minten","year":"2025","unstructured":"Minten T, Bick S, Adelson S, Gehlenborg N, Amendola LM, Boemer F, et al. Data-driven consideration of genetic disorders for global genomic newborn screening programs. Genet Med. 2025;27:101443. https:\/\/doi.org\/10.1016\/j.gim.2025.101443.","journal-title":"Genet Med"},{"key":"2107_CR6","doi-asserted-by":"publisher","first-page":"e2331162","DOI":"10.1001\/jamanetworkopen.2023.31162","volume":"6","author":"T Chen","year":"2023","unstructured":"Chen T, Fan C, Huang Y, Feng J, Zhang Y, Miao J, et al. Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening. JAMA Netw Open. 2023;6:e2331162 https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.31162.","journal-title":"JAMA Netw Open"},{"key":"2107_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom R, Wright CF. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts. Front Genet. 2022;13:920390. https:\/\/doi.org\/10.3389\/fgene.2022.920390.","journal-title":"Front Genet"},{"key":"2107_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","volume":"93","author":"LKL Portocarrero","year":"2018","unstructured":"Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado M. Tuberous sclerosis complex: review based on new diagnostic criteria. Bras Dermatol. 2018;93:323\u201331. https:\/\/doi.org\/10.1590\/abd1806-4841.20186972.","journal-title":"Bras Dermatol"},{"key":"2107_CR9","unstructured":"Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous Sclerosis Complex; In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds). GeneReviews(\u00ae). University of Washington, Seattle, Seattle (WA): 1993."},{"key":"2107_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51:1236\u201341. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02474.x.","journal-title":"Epilepsia"},{"key":"2107_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"The Wellcome Trust Case Control Consortium","year":"2007","unstructured":"The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447:661\u201378. https:\/\/doi.org\/10.1038\/nature05911.","journal-title":"Nature"},{"key":"2107_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.seizure.2019.08.010","volume":"71","author":"S Lin","year":"2019","unstructured":"Lin S, Zeng JB, Zhao GX, Yang ZZ, Huang HP, Lin MT, et al. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1\/TSC2 genes. Seizure. 2019;71:322\u20137. https:\/\/doi.org\/10.1016\/j.seizure.2019.08.010.","journal-title":"Seizure"},{"key":"2107_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10048-018-0551-y","volume":"19","author":"RC Caylor","year":"2018","unstructured":"Caylor RC, Grote L, Thiffault I, Farrow EG, Willig L, Soden S, et al. Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings. Neurogenetics. 2018;19:205\u201313. https:\/\/doi.org\/10.1007\/s10048-018-0551-y.","journal-title":"Neurogenetics"},{"key":"2107_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1177\/0883073807307093","volume":"22","author":"DA Lyczkowski","year":"2007","unstructured":"Lyczkowski DA, Conant KD, Pulsifer MB, Jarrett DY, Grant PE, Kwiatkowski DJ, et al. Intrafamilial phenotypic variability in tuberous sclerosis complex. J Child Neurol. 2007;22:1348\u201355. https:\/\/doi.org\/10.1177\/0883073807307093.","journal-title":"J Child Neurol"},{"key":"2107_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/01.wnl.0000113745.58425.ef","volume":"62","author":"A Humphrey","year":"2004","unstructured":"Humphrey A, Higgins JN, Yates JR, Bolton PF. Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology. 2004;62:795\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000113745.58425.ef.","journal-title":"Neurology"},{"key":"2107_CR16","doi-asserted-by":"publisher","unstructured":"Togi S, Ura H, Hatanaka H, Niida Y. Genotype and Phenotype Landscape of 283 Japanese Patients with Tuberous Sclerosis Complex. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms231911175.","DOI":"10.3390\/ijms231911175"},{"key":"2107_CR17","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/brain\/awaf072","volume":"148","author":"A Dhawan","year":"2025","unstructured":"Dhawan A, Kumar H, Huang H, Gupta A. Phenotypic clustering in tuberous sclerosis complex reveals four distinct disease trajectories. Brain : a J Neurol. 2025;148:2912\u20139. https:\/\/doi.org\/10.1093\/brain\/awaf072.","journal-title":"Brain : a J Neurol"},{"key":"2107_CR18","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","volume":"109","author":"UL Mirshahi","year":"2022","unstructured":"Mirshahi UL, Colclough K, Wright CF, Wood AR, Beaumont RN, Tyrrell J, et al. Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts. Am J Hum Genet. 2022;109:2018\u201328. https:\/\/doi.org\/10.1016\/j.ajhg.2022.09.014.","journal-title":"Am J Hum Genet"},{"key":"2107_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamacardio.2022.0901","volume":"7","author":"AP Patel","year":"2022","unstructured":"Patel AP, Dron JS, Wang M, Pirruccello JP, Ng K, Natarajan P, et al. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality. JAMA Cardiol. 2022;7:723\u201332. https:\/\/doi.org\/10.1001\/jamacardio.2022.0901.","journal-title":"JAMA Cardiol"},{"key":"2107_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102159","volume":"64","author":"L Jackson","year":"2023","unstructured":"Jackson L, Weedon MN, Green HD, Mallabar-Rimmer B, Harrison JW, Wood AR, et al. Influence of family history on penetrance of hereditary cancers in a population setting. EClinicalMedicine. 2023;64:102159. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102159.","journal-title":"EClinicalMedicine"},{"key":"2107_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajhg.2018.12.015","volume":"104","author":"CF Wright","year":"2019","unstructured":"Wright CF, West B, Tuke M, Jones SE, Patel K, Laver TW, et al. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting. Am J Hum Genet. 2019;104:275\u201386. https:\/\/doi.org\/10.1016\/j.ajhg.2018.12.015.","journal-title":"Am J Hum Genet"},{"key":"2107_CR22","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1007\/s00381-020-04726-z","volume":"36","author":"D Marom","year":"2020","unstructured":"Marom D. Genetics of tuberous sclerosis complex: an update. Child\u2019s Nerv Syst. 2020;36:2489\u201396. https:\/\/doi.org\/10.1007\/s00381-020-04726-z.","journal-title":"Child\u2019s Nerv Syst"},{"key":"2107_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/s0140-6736(86)92697-8","volume":"2","author":"JM Connor","year":"1986","unstructured":"Connor JM, Stephenson JB, Hadley MD. Non-penetrance in tuberous sclerosis. Lancet. 1986;2:1275. https:\/\/doi.org\/10.1016\/s0140-6736(86)92697-8.","journal-title":"Lancet"},{"key":"2107_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmg.28.6.417","volume":"28","author":"DW Webb","year":"1991","unstructured":"Webb DW, Osborne JP. Non-penetrance in tuberous sclerosis. J Med Genet. 1991;28:417\u20139. https:\/\/doi.org\/10.1136\/jmg.28.6.417.","journal-title":"J Med Genet"},{"key":"2107_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147566","volume":"877","author":"LS Farach","year":"2023","unstructured":"Farach LS, Northrup H, Nellist M, van Unen L, Hillman P, Klonowska K, et al. Mild TSC phenotype and non-penetrance associated with a frameshift variant in TSC2 prompts caution in evaluating pathogenicity of frameshift variants. Gene. 2023;877:147566. https:\/\/doi.org\/10.1016\/j.gene.2023.147566.","journal-title":"Gene"},{"key":"2107_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-018-0611-z","volume":"19","author":"F Wang","year":"2018","unstructured":"Wang F, Xiong S, Wu L, Chopra M, Hu X, Wu B. A novel TSC2 missense variant associated with a variable phenotype of tuberous sclerosis complex: case report of a Chinese family. BMC Med Genet. 2018;19:90. https:\/\/doi.org\/10.1186\/s12881-018-0611-z.","journal-title":"BMC Med Genet"},{"key":"2107_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ana.21037","volume":"60","author":"AC Jansen","year":"2006","unstructured":"Jansen AC, Sancak O, D\u2019Agostino MD, Badhwar A, Roberts P, Gobbi G, et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol. 2006;60:528\u201339. https:\/\/doi.org\/10.1002\/ana.21037.","journal-title":"Ann Neurol"},{"key":"2107_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.a.38083","volume":"173","author":"LS Farach","year":"2017","unstructured":"Farach LS, Gibson WT, Sparagana SP, Nellist M, Stumpel CT, Hietala M, et al. TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complex. Am J Med Genet Part A. 2017;173:771\u20135. https:\/\/doi.org\/10.1002\/ajmg.a.38083.","journal-title":"Am J Med Genet Part A"},{"key":"2107_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50\u201366. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.07.011.","journal-title":"Pediatr Neurol"},{"key":"2107_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z.","journal-title":"Nature"},{"key":"2107_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41586-025-09272-9","volume":"645","author":"UK Biobank Whole-Genome Sequencing Consortium","year":"2025","unstructured":"UK Biobank Whole-Genome Sequencing Consortium. Whole-genome sequencing of 490,640 UK Biobank participants. Nature. 2025;645:692\u2013701. https:\/\/doi.org\/10.1038\/s41586-025-09272-9.","journal-title":"Nature"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, et al. The \u201cAll of Us\u201d Research Program. N Engl J Med. 2019;381:668\u201376. https:\/\/doi.org\/10.1056\/NEJMsr1809937.","journal-title":"N Engl J Med"},{"key":"2107_CR33","unstructured":"National Institutes of Health. Data Browser. 2025. https:\/\/databrowser.researchallofus.org\/."},{"key":"2107_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"key":"2107_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535\u2013548.e524. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015.","journal-title":"Cell"},{"key":"2107_CR36","doi-asserted-by":"publisher","unstructured":"The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 2020; 369:1318\u201330; https:\/\/doi.org\/10.1126\/science.aaz1776.","DOI":"10.1126\/science.aaz1776"},{"key":"2107_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/humu.22951","volume":"37","author":"R Ekong","year":"2016","unstructured":"Ekong R, Nellist M, Hoogeveen-Westerveld M, Wentink M, Panzer J, Sparagana S, et al. Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis. Hum Mutat. 2016;37:364\u201370. https:\/\/doi.org\/10.1002\/humu.22951.","journal-title":"Hum Mutat"},{"key":"2107_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"key":"2107_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/nar\/26.1.285","volume":"26","author":"DN Cooper","year":"1998","unstructured":"Cooper DN, Ball EV, Krawczak M. The human gene mutation database. Nucleic Acids Res. 1998;26:285\u20137. https:\/\/doi.org\/10.1093\/nar\/26.1.285.","journal-title":"Nucleic Acids Res"},{"key":"2107_CR40","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u2013d1067. https:\/\/doi.org\/10.1093\/nar\/gkx1153.","journal-title":"Nucleic Acids Res"},{"key":"2107_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","volume":"22","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, Roberto D, Graziola F. Genotype\/Phenotype Correlations in Tuberous Sclerosis Complex. Semin Pediatr Neurol. 2015;22:259\u201373. https:\/\/doi.org\/10.1016\/j.spen.2015.10.002.","journal-title":"Semin Pediatr Neurol"},{"key":"2107_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ane.13416","volume":"144","author":"A Vignoli","year":"2021","unstructured":"Vignoli A, La Briola F, Turner K, Peron A, Vannicola C, Chiesa V, et al. Epilepsy in adult patients with tuberous sclerosis complex. Acta Neurol Scand. 2021;144:29\u201340. https:\/\/doi.org\/10.1111\/ane.13416.","journal-title":"Acta Neurol Scand"},{"key":"2107_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ajmg.c.31651","volume":"178","author":"A Peron","year":"2018","unstructured":"Peron A, Au KS, Northrup H. Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice. Am J Med Genet C Semin Med Genet. 2018;178:281\u201390. https:\/\/doi.org\/10.1002\/ajmg.c.31651.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"2107_CR44","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41436-020-0823-4","volume":"22","author":"B Og\u00f3rek","year":"2020","unstructured":"Og\u00f3rek B, Hamieh L, Hulshof HM, Lasseter K, Klonowska K, Kuijf H, et al. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study. Genet Med. 2020;22:1489\u201397. https:\/\/doi.org\/10.1038\/s41436-020-0823-4.","journal-title":"Genet Med"},{"key":"2107_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2023.10.008","volume":"150","author":"Z Ye","year":"2024","unstructured":"Ye Z, Lin S, Zhao X, Wallis M, Gao X, Sun L, et al. Are Germline Mosaic TSC1\/2 Variants Present in Controls? Implications for Diagnosis. Pediatr Neurol. 2024;150:37\u201339. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2023.10.008.","journal-title":"Pediatr Neurol"},{"key":"2107_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.26.25322940","author":"SA Felker","year":"2025","unstructured":"Felker SA, Korf BR, Barsh GS. Genotype-First Assessment of Presentation and Penetrance of Neurofibromatosis Type 1, Autosomal Dominant Polycystic Kidney Disease, and Marfan Syndrome Within the All of Us Research Program Cohort. medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.02.26.25322940.","journal-title":"medRxiv"},{"key":"2107_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.38.5.347","volume":"38","author":"L Khare","year":"2001","unstructured":"Khare L, Strizheva GD, Bailey JN, Au KS, Northrup H, Smith M, et al. A novel missense mutation in the GTPase activating protein homology region of TSC2 in two large families with tuberous sclerosis complex. J Med Genet. 2001;38:347\u20139. https:\/\/doi.org\/10.1136\/jmg.38.5.347.","journal-title":"J Med Genet"},{"key":"2107_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"2107_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61698-x","volume":"16","author":"S Gudmundsson","year":"2025","unstructured":"Gudmundsson S, Singer-Berk M, Stenton SL, Goodrich JK, Wilson MW, Einson J, et al. Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database. Nat Commun. 2025;16:9623. https:\/\/doi.org\/10.1038\/s41467-025-61698-x.","journal-title":"Nat Commun"},{"key":"2107_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2025.101532","volume":"27","author":"J Kaplanis","year":"2025","unstructured":"Kaplanis J, Deen D, Sivakumar P, de Almeida Gomes M, Puzriakova A, Leong I, et al. Assessment of the variant prioritization strategy for genomic newborn screening in the Generation Study. Genet Med. 2025;27:101532. https:\/\/doi.org\/10.1016\/j.gim.2025.101532.","journal-title":"Genet Med"},{"key":"2107_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02443-1","volume":"17","author":"C Luo","year":"2022","unstructured":"Luo C, Zhang Y, Zhang YS, Zhang MX, Ning J, Chen MF, et al. Renal phenotypes correlate with genotypes in unrelated individuals with tuberous sclerosis complex in China. Orphanet J Rare Dis. 2022;17:288. https:\/\/doi.org\/10.1186\/s13023-022-02443-1.","journal-title":"Orphanet J Rare Dis"},{"key":"2107_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41581-024-00818-0","volume":"20","author":"D Mekahli","year":"2024","unstructured":"Mekahli D, M\u00fcller R-U, Marlais M, Wlodkowski T, Haeberle S, de Argumedo ML, et al. Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group. Nat Rev Nephrol 2024;20:402\u201320. https:\/\/doi.org\/10.1038\/s41581-024-00818-0.","journal-title":"Nat Rev Nephrol"},{"key":"2107_CR53","unstructured":"UK Biobank. Showcase data browser. https:\/\/biobank.ctsu.ox.ac.uk\/ukb\/."},{"key":"2107_CR54","unstructured":"National Institutes of Health. Data Snapshots. 2025. https:\/\/www.researchallofus.org\/data-tools\/data-snapshots\/."},{"key":"2107_CR55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186:1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"},{"key":"2107_CR56","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","volume":"20","author":"C Kingswood","year":"2016","unstructured":"Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20:296\u2013308. https:\/\/doi.org\/10.1016\/j.ejpn.2015.11.011.","journal-title":"Eur J Paediatr Neurol"},{"key":"2107_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0764-z","volume":"13","author":"M S\u0142owi\u0144ska","year":"2018","unstructured":"S\u0142owi\u0144ska M, J\u00f3\u017awiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, et al. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?. Orphanet J Rare Dis. 2018;13:25. https:\/\/doi.org\/10.1186\/s13023-018-0764-z.","journal-title":"Orphanet J Rare Dis"},{"key":"2107_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou X, Edmonson MN, Wilkinson MR, Patel A, Wu G, Liu Y, et al. Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat Genet. 2016;48:4\u20136. https:\/\/doi.org\/10.1038\/ng.3466.","journal-title":"Nat Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02107-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:14:31Z","timestamp":1779113671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02107-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":58,"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02107-9","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"UK Biobank protocols were approved by the National Research Ethics Service Committee. Approval for the release of this research, with an exception to report participant\/incident counts relating to fewer than 5 individuals, was granted by the Epidemiology team. The institutional review board for the All of Us Research Program provides centralised ethical approval and oversight for the research programme. Approval for the release of this research was granted by the All of Us Research Program Publication Board. An exception was granted to this project by the Resource Access Board allowing us to report participant\/incident counts relating to fewer than 20 individuals. Consistent with the governance frameworks of UK Biobank and the All of Us Research Program, participants were not recontacted and further informed consent specifically related to this study was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}